세계의 HLA 타이핑 시장 : 제품 유형별(기기, 소프트웨어), 기술별(분자 : PCR, 시퀀싱/혈청), 용도별(진단, 연구), 최종사용자별, 지역별 예측(-2029년)
HLA Typing Market by Product (Instruments, Software), Technology (Molecular [PCR, Sequencing ], Serology), Application (Diagnostics, Research), End User, and Geography - Forecast to 2029
세계의 HLA 타이핑 시장 규모는 2022-2029년 5.6%의 CAGR로 성장하며, 2029년에는 19억 달러에 달할 것으로 예측되고 있습니다. 시장의 성장을 지원하는 주요 요인으로는 장기 이식의 증가, HLA 타이핑에 사용되는 분자 어세이의 기술적 진보, 장기 제공에 관한 사람들의 의식 향상 등을 들 수 있습니다.
세계의 HLA 타이핑 시장을 조사했으며, 시장의 개요, 시장 규모 및 예측, 동향, 촉진요인·억제요인, 경쟁 구도, 제품 유형별·기술별·용도별·최종사용자별·지역별 분석 및 기업 개요 등을 정리하여 전해드립니다.
HLA Typing Market by Product (Instruments, Software), Technology (Molecular [PCR, Sequencing [Sangers, NGS]], Serology), Application (Diagnostics [Cross Match, Cancer, Infectious Disease], Research), End User, and Geography - Global Forecast to 2029
The Global HLA Typing Market is expected to grow at a CAGR of 5.6% from 2022 to 2029 to reach $1.90 billion by 2029.
Succeeding an extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities. The growth in the HLA typing market is attributed to the increasing number of organ transplants and technological advancements in the molecular assays used for HLA typing. In addition, the increasing awareness amongst people regarding organ donations offers a growth opportunity for the HLA typing market.
Based on product, in 2022, the consumables segment is estimated to account for the largest share of the HLA typing market. High demand for consumables, availability of diverse consumables, and companies focused on launching new HLA typing consumables contribute to the growth of this segment. For instance, in 2020, Omixon Inc. (U.S.) launched an 11-locus multiplex HLA genotyping assay.
Based on technology, in 2022, the molecular technologies segment is estimated to account for the largest share of the HLA typing market. Advancements and benefits of molecular technologies compared to non-molecular technologies contribute to the large share of this segment.
Based on application, in 2022, the diagnostics segment is expected to account for the largest share of the HLA typing market. The high prevalence of chronic and metabolic diseases leading to organ failures is responsible for the largest segment share. The application of HLA typing for donor-recipient cross-matching, infectious disease pathogenesis, and transfusion is rising, contributing to the largest segment share.
Based on end user, in 2022, the diagnostic laboratories segment is estimated to account for the largest share of the HLA typing market. HLA typing products are frequently used in diagnostics laboratories for disease diagnosis and donor-recipient cross-matching. Outsourcing laboratory services by hospitals and transplant centers and consolidating diagnostics laboratories contribute to the large share of this segment. The partnerships or outsourcing of laboratory services provides benefits such as cost savings, efficiency gains, and the right allocation of resources. Thus, the increasing collaboration between hospitals/transplant centers with diagnostic laboratories results in adoption of HLA typing products by diagnostic laboratories.
An in-depth analysis of the geographical scenario of the HLA typing market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2022, North America is estimated to account for the largest share of the HLA typing market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. The highest number of organ transplants, high prevalence of chronic diseases, high spending on healthcare, and well-established healthcare infrastructure are the primary factors responsible for the large share of the North American HLA typing market.
Some of the key players operating in the global HLA typing market are Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Genome Diagnostics B.V. (GenDx) (Netherlands), Illumina, Inc. (U.S.), CareDx (U.S.), Immucor Inc. (U.S.), TBG Diagnostics Limited (Australia), BAG Diagnostic GmbH (Germany), Omixon Inc. (Hungary), Luminex Corporation (U.S.), inno-train Diagnostik GmbH (Germany), Pacific Biosciences of California, Inc. (U.S.), and Fujirebio Holdings, Inc. (Japan).
HLA Typing Market, by Product
HLA Typing Market, by Technology
Other PCR-based molecular techniques include RPLF-PCR, SNP-PCR, and PCR-SSCP.
HLA Typing Market, by Application
Other diagnostic applications include Autoimmune Disease Diagnosis, Cancer Diagnosis, Infectious Disease Testing and Paternity testing.
HLA Typing Market, by End Users
HLA Typing Market, by Geography